Search for a clinical trial
Other search option(s)
6 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
CCRN 292: A 24-week with possible extension, prospective, multicentre, randomized, double blind, placebo-controlled, 2-parallel group with a randomization 1:1, Phase III study to compare efficacy and safety of masitinib at 6 mg/kg/day to placebo in treatment of patients with Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis with handicap - ES
Institution: Information not provided - ES
GERMANY
Berlin
BERLIN
A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis - DE - Prematurely Ended
Charité - Universitätsmedizin Berlin (CCM)
Allergie-Centrum-Charité / Klinik für Dermatologie, Venerologie und Allergologie
FRANCE
ILE-DE-FRANCE
VILLEJUIF
(APL-A-005-02) Phase I - II clinical and pharmacokinetic study of Aplidin (APL) as a 3-hour intravenous infusion every 2 weeks, in children with refractory or relapsed malignant tumours and leukaemia -Terminated -
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent
CANADA
Ontario
HAMILTON
FGFR Study: Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours - UK
McMaster University
Department of Medicine
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
An Open-Label Phase I/IIa Study of Intravenous BAL101553 in Adult Patients with Advanced Solid Tumors
Institution: Information not provided - UK
Multinational clinical trial(s)
SPAIN
Madrid
COLMENAR VIEJO